MCS110
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MCS110, covering 2019-04-09 to 2024-07-31. Get the full timeline:
Most recent: Clinical Trial Update: MCS110 With BRAF/MEK Inhibition in Patients With Melanoma [Phase 1, Phase 2]